Disease Course in Oncological Patients During Inpatient Rehabilitation and After Three Months Follow-up

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-01

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Constant improvements in the areas of diagnostics and treatment lead to an increase of patients surviving an oncological diagnosis ("cancer survivors") thus increasing the cost factor on both society and health care systems. Meta-analysis have shown the effectiveness of multidimensional rehabilitation programs concerning cost-effectiveness and for improving different health parameters. However when submitted to oncological rehabilitation in Switzerland there is no clear definition when to use which specific assessment during the different stages of oncological rehabilitation.

This cohort study aims to evaluate and systematically follow-up patients that are assigned for oncological inpatient rehabilitation at the Rehabilitation Center Walenstadtberg.

The main purposes are i) to evaluate disease onset of oncological patients during rehabilitation and to identify relationships between mobility and cancer-related fatigue at discharge; ii) to identify predictive factors for everyday functioning and social participation after three months discharge.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Psychological Distress in Outpatient Oncological Rehabilitation

NCT04324320

Distress Oncology

UNKNOWN

Evaluation of an Oncological Rehabilitation Program as Part of the Promotion of Therapeutic Physical Activity in Adults Cancer Patients

NCT06945757

Cancer Rehabilitation

RECRUITING

Involvement of Patients and Relatives in the Course of Cancer Disease

NCT01060761

Rehabilitation Cancer Relatives

COMPLETED NA

Digitizing Cancer Rehabilitation During and After Systemic Treatment: Feasibility Testing Implementation in South Baltic Countries

NCT06768918

Cancer Rehabilitation Cancer

RECRUITING NA

Optimized Rehabilitation Following Primary Breast Cancer Surgery

NCT03434717

Rehabilitation Breast Neoplasms Psychological Distress

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oncologic Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oncologic disorders

All patients assigned for oncological rehabilitation with the diagnosis "Cancer" are included to this cohort.

Oncological Rehabilitation

Intervention Type BEHAVIORAL

Multidimensional rehabilitation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oncological Rehabilitation

Multidimensional rehabilitation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with "Cancer";
* Literacy and understanding German language;
* Signed informed consent;

Exclusion Criteria

* Women who are pregnant or breastfeeding / have the intention to become pregnant during the course of the study;
* Other clinically significant concomitant disease states (e.g. renal failure, hepatic dysfunction, cardiovascular disease, etc);
* Known or suspected non-compliance, drug or alcohol abuse;
* Inability to follow the procedures of the study: e.g. due to language problems, psychological disorders, dementia of the participant, etc;
* Enrolment of the investigator, his/her family members, employees and other dependent persons;
* Cognitive impairment: Mini-Mental State Examination (MMSE) \< 21;
* Major Depression or Hospital Anxiety and Depression Scale (HADS) \>11 at baseline.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No